Nivolumab/relatlimab Interactions
There are 596 drugs known to interact with nivolumab/relatlimab, along with 5 disease interactions. Of the total drug interactions, 3 are major, and 593 are moderate.
- View all 596 medications that may interact with nivolumab/relatlimab
- View nivolumab/relatlimab disease interactions (5)
Most frequently checked interactions
View interaction reports for nivolumab / relatlimab and the medicines listed below.
- Aleve (naproxen)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Cardizem (diltiazem)
- Centrum Silver (multivitamin with minerals)
- Citracal + D (calcium / vitamin d)
- Collagenase Santyl (collagenase topical)
- CoQ10 (ubiquinone)
- Edarbi (azilsartan medoxomil)
- Edarbyclor (azilsartan medoxomil / chlorthalidone)
- Eliquis (apixaban)
- Flonase (fluticasone nasal)
- Flonase Allergy Relief (fluticasone nasal)
- Jardiance (empagliflozin)
- Keflex (cephalexin)
- Lovaza (omega-3 polyunsaturated fatty acids)
- Macrodantin (nitrofurantoin)
- Metamucil (psyllium)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Myrbetriq (mirabegron)
- Phillips Stool Softener (docusate)
- Plavix (clopidogrel)
- PreserVision AREDS Lutein (multivitamin with minerals)
- SMZ-TMP DS (sulfamethoxazole / trimethoprim)
- Tolak (fluorouracil topical)
- Trulicity (dulaglutide)
- Tylenol (acetaminophen)
- Tylenol Arthritis Pain (acetaminophen)
- Tylenol Extra Strength (acetaminophen)
Nivolumab/relatlimab disease interactions
There are 5 disease interactions with nivolumab / relatlimab which include:
Report options
QR code containing a link to this page
More about nivolumab / relatlimab
- nivolumab/relatlimab consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
